Piascledin® 300 Efficacy in the Management of Osteoarthritis: Proved in Clinical Trials, Confirmed by European Practice

O.P. Bortkevych


The problem of osteoarthritis management and its new approaches are discussed in the article. The new SYSADOA preparation Piascledin® 300, which had been used worldwide for hip and knee osteoarthritis, has appeared in Ukraine. European evidence based data for Piascledin® 300 efficacy and advantages of its admi-nistration are presented in the article.


osteoarthritis; Piascledin® 300; cytokines; transfor-ming growth factor; clinical trials


Copyright (c) 2016 TRAUMA

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019


   Seo анализ сайта